BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31250622)

  • 1. Heterogeneous Sequences of Brain Cytoplasmic 200 RNA Formed by Multiple Adenine Nucleotide Insertions.
    Shin H; Lee J; Kim Y; Jang S; Kim M; Lee Y
    Mol Cells; 2019 Jun; 42(6):495-500. PubMed ID: 31250622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of BC200 RNA-mediated translation inhibition by hnRNP E1 and E2.
    Jang S; Shin H; Lee J; Kim Y; Bak G; Lee Y
    FEBS Lett; 2017 Jan; 591(2):393-405. PubMed ID: 28027391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA Helicase Associated with AU-rich Element (RHAU/DHX36) Interacts with the 3'-Tail of the Long Non-coding RNA BC200 (BCYRN1).
    Booy EP; McRae EK; Howard R; Deo SR; Ariyo EO; Dzananovic E; Meier M; Stetefeld J; McKenna SA
    J Biol Chem; 2016 Mar; 291(10):5355-72. PubMed ID: 26740632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthesis of brain cytoplasmic 200 RNA.
    Kim Y; Lee J; Shin H; Jang S; Kim SC; Lee Y
    Sci Rep; 2017 Jul; 7(1):6884. PubMed ID: 28761139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of RNA motifs essential for BC200 RNA-mediated translational regulation.
    Jang S; Shin H; Lee Y
    BMB Rep; 2020 Feb; 53(2):94-99. PubMed ID: 31234958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying the cellular location of brain cytoplasmic 200 RNA using an RNA-recognizing antibody.
    Shin H; Lee J; Kim Y; Jang S; Ohn T; Lee Y
    BMB Rep; 2017 Jun; 50(6):318-322. PubMed ID: 28042783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The DEAD-box helicase eIF4A: paradigm or the odd one out?
    Andreou AZ; Klostermeier D
    RNA Biol; 2013 Jan; 10(1):19-32. PubMed ID: 22995829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective targeting of the DEAD-box RNA helicase eukaryotic initiation factor (eIF) 4A by natural products.
    Shen L; Pelletier J
    Nat Prod Rep; 2020 May; 37(5):609-616. PubMed ID: 31782447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor.
    Iwasaki S; Floor SN; Ingolia NT
    Nature; 2016 Jun; 534(7608):558-61. PubMed ID: 27309803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The noncoding RNA BC200 associates with polysomes to positively regulate mRNA translation in tumor cells.
    Booy EP; Gussakovsky D; Choi T; McKenna SA
    J Biol Chem; 2021; 296():100036. PubMed ID: 33410401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase.
    Steinhardt JJ; Peroutka RJ; Mazan-Mamczarz K; Chen Q; Houng S; Robles C; Barth RN; DuBose J; Bruns B; Tesoriero R; Stein D; Fang R; Hanna N; Pasley J; Rodriguez C; Kligman MD; Bradley M; Rabin J; Shackelford S; Dai B; Landon AL; Scalea T; Livak F; Gartenhaus RB
    Blood; 2014 Dec; 124(25):3758-67. PubMed ID: 25320244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting RNA helicases in cancer: The translation trap.
    Heerma van Voss MR; van Diest PJ; Raman V
    Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):510-520. PubMed ID: 28965870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome-wide characterization of the eIF4A signature highlights plasticity in translation regulation.
    Rubio CA; Weisburd B; Holderfield M; Arias C; Fang E; DeRisi JL; Fanidi A
    Genome Biol; 2014; 15(10):476. PubMed ID: 25273840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual targeting of DDX3 and eIF4A by the translation inhibitor rocaglamide A.
    Chen M; Asanuma M; Takahashi M; Shichino Y; Mito M; Fujiwara K; Saito H; Floor SN; Ingolia NT; Sodeoka M; Dodo K; Ito T; Iwasaki S
    Cell Chem Biol; 2021 Apr; 28(4):475-486.e8. PubMed ID: 33296667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coupling between the DEAD-box RNA helicases Ded1p and eIF4A.
    Gao Z; Putnam AA; Bowers HA; Guenther UP; Ye X; Kindsfather A; Hilliker AK; Jankowsky E
    Elife; 2016 Aug; 5():. PubMed ID: 27494274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SYNCRIP, a component of dendritically localized mRNPs, binds to the translation regulator BC200 RNA.
    Duning K; Buck F; Barnekow A; Kremerskothen J
    J Neurochem; 2008 Apr; 105(2):351-9. PubMed ID: 18045242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BC200 RNA: An Emerging Therapeutic Target and Diagnostic Marker for Human Cancer.
    Shin H; Kim Y; Kim M; Lee Y
    Mol Cells; 2018 Dec; 41(12):993-999. PubMed ID: 30590906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long non-coding RNA BC200 (BCYRN1) is critical for cancer cell survival and proliferation.
    Booy EP; McRae EK; Koul A; Lin F; McKenna SA
    Mol Cancer; 2017 Jun; 16(1):109. PubMed ID: 28651607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of the BC200 ribonucleoprotein reveals a reciprocal regulatory function with CSDE1/UNR.
    Booy EP; McRae EK; Ezzati P; Choi T; Gussakovsky D; McKenna SA
    Nucleic Acids Res; 2018 Nov; 46(21):11575-11591. PubMed ID: 30247708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA-mediated sequestration of the RNA helicase eIF4A by Pateamine A inhibits translation initiation.
    Bordeleau ME; Cencic R; Lindqvist L; Oberer M; Northcote P; Wagner G; Pelletier J
    Chem Biol; 2006 Dec; 13(12):1287-95. PubMed ID: 17185224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.